Chemokine (C-C motif) Ligand 2 Is Regulated Through the EGFR/Src Pathway in HER2-positive Breast Cancer Cells
Daeun You(Samsung Medical Center), SANGMIN KIM(Samsung Medical Center)
Cited by 4
Related Papers
Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells
|Oncology Reports|2021|38
Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
|BMB Reports|2017|27
Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages
|International Journal of Molecular Sciences|2023|10
Wild-type p53 controls the level of fibronectin expression in breast cancer cells
|Oncology Reports|2017|9